CR
Curis, Inc.
CRIS · NASDAQ
$0.80 -3.29% (-$0.03)
1M -40.49%
Market Cap $1.62M
P/E Ratio -
Div. Yield -
ROE 1,035.26%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
0/9Valuation
100 /100
Cheap P/S 0.38x
P/B 0.34x
P/E N/A
Growth
6 /100
Declining Rev. growth 2.42%
Book val. growth 51.04%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 99.28%
Net margin 490.33%
Op. margin 833.40%
Quality
3 /100
Poor ROIC 567.17%
ROE 1,035.26%
ROA 111.51%
Debt
69 /100
Low Debt/Equity 0.22x
Current ratio 0.49x
Int. coverage N/A
Stability
42 /100
Moderate Beta 3.00x
Rev. volatility 11.14%
EPS volatility 38.63%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CRIS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James Dentzer
Employees
22
Headquarters
Lexington
Upcoming events
05 NOV
Earnings
Upcoming earnings report